Position in JNJ
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$7,378,082
+$765,492 QoQ
Shares Held
29,051
+7.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#1,305
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CITY HOLDING CO holds $54,117,792 across 11 Drug Manufacturers - General names. JNJ ranks #3 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
23,405 | $28,072,660 | |
| 2 | ABBV |
AbbVie Inc.
|
43,975 | $11,065,869 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
29,051 | $7,378,082 | |
| 4 | AMGN |
Amgen Inc
|
12,282 | $4,447,557 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,085 | $1,424,422 | |
| 6 | PFE |
Pfizer Inc
|
35,409 | $852,648 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
14,061 | $810,194 | |
| 8 | NVS |
Novartis AG
|
190 | $29,776 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,378,082 | 29,051 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $6,612,590 | 27,052 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $4,644,785 | 22,444 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $3,977,073 | 21,449 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $3,349,043 | 21,925 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $3,672,195 | 22,143 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $3,327,850 | 23,011 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $3,829,963 | 23,633 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $3,689,516 | 25,243 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $4,164,826 | 26,328 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $4,342,168 | 27,703 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $4,942,103 | 31,731 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $5,297,798 | 32,007 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $4,979,220 | 32,124 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $5,731,409 | 32,445 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $5,295,314 | 32,415 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $5,821,440 | 32,795 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $5,943,408 | 33,535 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $5,801,325 | 33,912 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $5,816,422 | 36,015 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $6,038,379 | 36,654 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $6,042,985 | 36,769 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $5,627,594 | 35,758 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $5,352,831 | 35,954 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $5,014,162 | 35,655 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $4,415,015 | 33,669 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||